Tag: AHA 2020

AHA 2020: AF detected more often in high risk patients recovering...

Atrial fibrillation (AF) was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac...

AHA 2020: Patients taking statins experience similar side effects from placebos

Among patients who stopped taking statins due to side effects, researchers found the statin may not have been the culprit as patients taking a...

AHA 2020: One-month DAPT safe and feasible after stent placement

A one-month treatment of dual anti-platelet therapy (DAPT) is safe and as effective as a longer duration of therapy at preventing cardiac events in...

AHA 2020: Ticagrelor not superior to clopidogrel in reducing severe complications...

The use of ticagrelor was not superior to clopidogrel in the reduction of the rate of severe complications among patients undergoing percutaneous coronary intervention...

AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation...

The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart disease and Atrial Fibrillation—show that rivaroxaban is comparable to warfarin for patients with bioprosthetic...